Performance analysis of Cytosorbents (CTSO)
Annual Return
Over the past 3 years, CTSO has had an average annual return of -45.88%, underperforming the benchmark SPY, which returned +22.45% annual.
Over the past 5 years, CTSO has had an average annual return of -43.11%, underperforming the benchmark SPY, which returned +13.88% annual.
Over the past 10 years, CTSO has had an average annual return of -19.82%, underperforming the benchmark SPY, which returned +15.44% annual.
Since Jan 2, 2013, CTSO has had an average annual return of -13.16%, underperforming the benchmark SPY, which returned +14.95% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -23.49% | -29.75% | -18.01% | -28.39% | -63.01% | -47.43% | +107.02% | -52.35% | +24.31% | +19.27% | -2.15% | -44.02% |
| 2014 | 2013 | ||||||||||
| +218.41% | -3.85% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -1.47% | +19.45% | -24.75% | +7.75% | -19.55% | -0.33% | -23.49% | ||||||
| 2025 | +10.43% | +5.50% | -5.67% | +1.01% | -16.83% | +52.34% | -33.60% | +11.01% | -1.00% | -14.89% | +2.04% | -21.19% | -29.75% |
| 2024 | -8.99% | -5.05% | -0.95% | -14.75% | +11.16% | -21.91% | +70.69% | -12.49% | +42.84% | -32.65% | -3.96% | -6.20% | -18.01% |
| 2023 | +84.53% | +7.69% | +9.41% | -27.30% | +21.23% | +20.88% | -0.55% | -27.74% | -27.12% | -18.10% | -22.08% | -7.50% | -28.39% |
| 2022 | -11.22% | +4.04% | -17.58% | -34.16% | -8.11% | +13.47% | +4.11% | -16.66% | -28.41% | +37.49% | -25.13% | +10.70% | -63.01% |
| 2021 | +31.62% | -10.20% | -7.86% | +6.57% | -12.54% | -6.67% | +0.79% | +25.76% | -15.15% | -27.46% | -16.47% | -14.84% | -47.43% |
| 2020 | +28.31% | +22.07% | +28.19% | +10.73% | +19.28% | -3.03% | -3.28% | -11.86% | -5.51% | -4.08% | +9.67% | -5.00% | +107.02% |
| 2019 | -7.30% | +7.88% | -6.31% | -4.89% | -12.36% | +4.75% | +6.21% | -36.47% | +12.78% | -5.57% | -16.00% | -3.51% | -52.35% |
| 2018 | +16.92% | +3.29% | -10.19% | +7.09% | +49.67% | +0.89% | +5.26% | +22.08% | -11.95% | -22.48% | +4.40% | -22.60% | +24.31% |
| 2017 | +1.84% | +1.80% | -20.36% | +15.56% | -19.23% | +2.38% | +15.70% | +3.51% | +20.39% | -0.81% | +13.82% | -7.14% | +19.27% |
Drawdown analysis of Cytosorbents (CTSO)
The maximum drawdown for the CTSO was -96.93%, occurring on May 21, 2026. This drawdown has not yet recovered.
The current CTSO drawdown is -96.74%.
Since Jan 2, 2013 CTSO has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 2 times
- 30% or more: 3 times
- 20% or more: 5 times
- 10% or more: 6 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -96.93% | Mar 23, 2015 | 2808 | May 21, 2026 | Ongoing | Ongoing | Ongoing |
| -40.63% | Feb 27, 2014 | 19 | Mar 26, 2014 | 188 | Dec 22, 2014 | 207 |
| -40.00% | Jan 8, 2013 | 195 | Oct 16, 2013 | 63 | Jan 16, 2014 | 258 |
| -29.93% | Jan 5, 2015 | 17 | Jan 29, 2015 | 18 | Feb 25, 2015 | 35 |
| -20.64% | Jan 22, 2014 | 12 | Feb 7, 2014 | 13 | Feb 27, 2014 | 25 |
| -10.01% | Dec 26, 2014 | 2 | Dec 30, 2014 | 2 | Jan 2, 2015 | 4 |
| -9.40% | Feb 25, 2015 | 6 | Mar 5, 2015 | 7 | Mar 16, 2015 | 13 |
| -7.69% | Jan 2, 2013 | 1 | Jan 3, 2013 | 1 | Jan 4, 2013 | 2 |